Aster DM Healthcare peers

·Pharma & HealthChart ›

Companies like Aster DM Healthcarelatest year

Aster DM HealthcareASTERDM · FY26 · this company
Market cap₹35,191
P/E90.20×
Sales growth+21.6%
ROE9.7%
Apollo Hospitals EnterpriseAPOLLOHOSP · FY26
Open ›
Market cap₹1,17,916
P/E60.72×
Sales growth+20.6%
ROE22.0%
Max Healthcare InstituteMAXHEALTH · FY26
Open ›
Market cap₹82,828
P/E57.39×
Sales growth+20.3%
ROE14.3%
Krishna Institute of Medical SciencesKIMS · FY26
Open ›
Market cap₹28,100
P/E116.50×
Sales growth+35.3%
ROE11.0%

Market cap and P/E at the last close; sales growth is the latest quarter on the same quarter a year before; ROE for the latest financial year.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

ASTERDM₹679.20

Aster DM Healthcare Ltd.

· Pharma & Health
₹ CrorePeersAPOLLOHOSPMAXHEALTHKIMSCOHANCEWOCKPHARMASYNGENEGLANDLALPATHLABMcap ₹35,191 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
ASTERDM
FY26
APOLLOHOSP
FY26
MAXHEALTH
FY26
KIMS
FY26
Peer
Average
Valuation — at last close
P/E90.20×60.72×◆ 57.39×116.50×78.21× +15%
P/B◆ 7.69×12.44×7.71×12.50×10.88× -29%
EV/EBITDA38.65×◆ 32.35×38.17×39.36×36.63× +6%
Market Cap₹35,191 Cr₹1.18L Cr₹82,828 Cr₹28,100 Cr₹76,281 Cr -54%
Growth
Revenue CAGR 3Y-26.99%14.94%◆ 22.43%21.12%19.50% -238%
Revenue CAGR 5Y-11.61%19.03%◆ 27.30%24.04%23.46% -149%
Net Income CAGR 3Y-3.51%◆ 33.35%9.34%-12.87%9.94% -135%
Revenue YoY (latest Q)21.60%20.56%20.31%◆ 35.33%25.40% -15%
Net Income YoY (latest Q)-68.70%◆ 38.41%-15.64%-56.00%-11.08% -520%
Profitability
EBITDA Margin19.41%14.94%◆ 26.79%20.54%20.76% -6%
Net Income Margin9.20%7.94%◆ 17.23%6.20%10.46% -12%
Return on Common Equity9.70%◆ 21.95%14.33%11.01%15.76% -38%
Return on Capital Employed9.90%◆ 18.20%12.63%9.09%13.31% -26%
Return on Assets5.80%◆ 9.35%8.89%3.59%7.28% -20%
Credit & Quality
Total Debt/Equity◆ 0.15×0.57×0.32×1.27×0.72× -79%
Interest Coverage5.18×6.44×◆ 7.64×2.56×5.55× -7%
Scale — latest FY
Revenue / Total Income₹4,643 Cr₹25,229 Cr₹8,373 Cr₹3,905 Cr₹12,502 Cr -63%
Net Income₹427 Cr₹2,003 Cr₹1,442 Cr₹242 Cr₹1,229 Cr -65%
Total Assets₹8,112 Cr₹22,197 Cr₹17,231 Cr₹7,759 Cr₹15,729 Cr -48%
EPS₹7.53₹135.04₹14.83₹6.03₹51.97 -86%
Book Value per Share₹88.31₹659.26₹110.43₹56.19₹275.29 -68%
◆ best value in the comp set per metric · Δ = subject vs average of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.